(UMI) Umicore S.A. - Ratings and Ratios
Cathode, Catalyst, Recycle, Cobalt, German
Description: UMI Umicore S.A.
Umicore S.A. (BR:UMI) is a global materials technology and recycling company with operations across various regions, including Europe, Asia-Pacific, North America, South America, and Africa. The company operates through four main segments: Battery Materials, Catalysis, Recycling, and Specialty Materials.
The companys diverse portfolio includes the development and manufacturing of cathode materials for lithium-ion batteries, automotive catalysts, precious metals refining, and management, as well as production of specialty materials such as cobalt and nickel products. Umicores products and services cater to various industries, including the automotive, pharmaceutical, fine chemicals, and electronics sectors.
To evaluate Umicores performance, key performance indicators (KPIs) such as revenue growth, EBITDA margin, and return on invested capital (ROIC) can be considered. With a market capitalization of approximately €3.47 billion, Umicores financials indicate a forward P/E ratio of 7.98, suggesting a relatively attractive valuation. However, the negative return on equity (RoE) of -38.96% raises concerns about the companys profitability.
Further analysis of Umicores segments reveals opportunities for growth in the Battery Materials and Recycling segments, driven by increasing demand for lithium-ion batteries and sustainable recycling practices. The companys Catalysis segment is also expected to benefit from the growing need for emissions control technologies. To assess the companys potential, it is essential to monitor KPIs such as segment-wise revenue growth, operating margins, and cash flow generation.
From a trading perspective, Umicores stock price has shown volatility, with an average true range (ATR) of 0.51, representing a 3.81% price movement. The stocks current price is €13.40, below its 20-day simple moving average (SMA20) of €14.74, indicating a potential short-term bearish trend. However, the long-term trend remains positive, with the stock price above its 200-day SMA of €10.21.
UMI Stock Overview
| Market Cap in USD | 3,755m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception |
UMI Stock Ratings
| Growth Rating | -35.2% |
| Fundamental | 31.7% |
| Dividend Rating | 41.8% |
| Return 12m vs S&P 500 | 3.13% |
| Analyst Rating | - |
UMI Dividends
| Dividend Yield 12m | 2.13% |
| Yield on Cost 5y | 0.75% |
| Annual Growth 5y | 26.19% |
| Payout Consistency | 94.4% |
| Payout Ratio | 46.3% |
UMI Growth Ratios
| Growth Correlation 3m | 40.8% |
| Growth Correlation 12m | 19.3% |
| Growth Correlation 5y | -92% |
| CAGR 5y | -16.43% |
| CAGR/Max DD 5y | -0.19 |
| Sharpe Ratio 12m | -0.91 |
| Alpha | 19.92 |
| Beta | 0.555 |
| Volatility | 34.19% |
| Current Volume | 352.8k |
| Average Volume 20d | 338.1k |
| Stop Loss | 12.9 (-3.3%) |
| Signal | -0.98 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (-1.09b TTM) > 0 and > 6% of Revenue (6% = 1.99b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 3.96pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 3.81% (prev 9.49%; Δ -5.68pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 1.86b > Net Income -1.09b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.29 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (240.5m) change vs 12m ago 0.10% (target <= -2.0% for YES) |
| Gross Margin 6.91% (prev 5.38%; Δ 1.53pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 342.3% (prev 255.8%; Δ 86.42pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -2.25 (EBITDA TTM -35.5m / Interest Expense TTM 275.4m) >= 6 (WARN >= 3) |
Altman Z'' 1.13
| (A) 0.13 = (Total Current Assets 5.61b - Total Current Liabilities 4.35b) / Total Assets 9.41b |
| (B) 0.11 = Retained Earnings (Balance) 1.07b / Total Assets 9.41b |
| (C) -0.06 = EBIT TTM -619.2m / Avg Total Assets 9.68b |
| (D) 0.29 = Book Value of Equity 2.20b / Total Liabilities 7.49b |
| Total Rating: 1.13 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 31.73
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 8.14% = 4.07 |
| 3. FCF Margin 1.34% = 0.34 |
| 4. Debt/Equity 2.20 = 0.47 |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC -23.21% = -12.50 |
| 7. RoE -38.96% = -2.50 |
| 8. Rev. Trend -84.78% = -4.24 |
| 9. Rev. CAGR 0.0% = 0.0 |
| 10. EPS Trend -36.26% = -0.91 |
| 11. EPS CAGR -25.53% = -2.50 |
What is the price of UMI shares?
Over the past week, the price has changed by -3.89%, over one month by -8.44%, over three months by +39.03% and over the past year by +20.63%.
Is Umicore S.A. a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UMI is around 12.84 EUR . This means that UMI is currently overvalued and has a potential downside of -3.75%.
Is UMI a buy, sell or hold?
What are the forecasts/targets for the UMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14 | 5.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 13.7 | 2.8% |
UMI Fundamental Data Overview
Market Cap EUR = 3.22b (3.22b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 2.01b EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 27.2245
P/E Forward = 7.9808
P/S = 0.2
P/B = 1.5902
P/EG = 2.11
Beta = 0.783
Revenue TTM = 33.12b EUR
EBIT TTM = -619.2m EUR
EBITDA TTM = -35.5m EUR
Long Term Debt = 3.14b EUR (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 1.12b EUR (from shortTermDebt, last quarter)
Debt = 4.26b EUR (Calculated: Short Term 1.12b + Long Term 3.14b)
Net Debt = 1.42b EUR (from netDebt column, last quarter)
Enterprise Value = 5.47b EUR (3.22b + Debt 4.26b - CCE 2.01b)
Interest Coverage Ratio = -2.25 (Ebit TTM -619.2m / Interest Expense TTM 275.4m)
FCF Yield = 8.14% (FCF TTM 445.2m / Enterprise Value 5.47b)
FCF Margin = 1.34% (FCF TTM 445.2m / Revenue TTM 33.12b)
Net Margin = -3.31% (Net Income TTM -1.09b / Revenue TTM 33.12b)
Gross Margin = 6.91% ((Revenue TTM 33.12b - Cost of Revenue TTM 30.83b) / Revenue TTM)
Tobins Q-Ratio = 2.49 (Enterprise Value 5.47b / Book Value Of Equity 2.20b)
Interest Expense / Debt = 1.72% (Interest Expense 73.0m / Debt 4.26b)
Taxrate = 76.20% (from quarterly Income Tax Expense: 40.4m / 53.0m)
NOPAT = -619.2m (EBIT -619.2m, no tax applied on loss)
Current Ratio = 1.29 (Total Current Assets 5.61b / Total Current Liabilities 4.35b)
Debt / Equity = 2.20 (Debt 4.26b / last Quarter total Stockholder Equity 1.94b)
Debt / EBITDA = -119.8 (Net Debt 1.42b / EBITDA -35.5m)
Debt / EBITDA = -119.8 --> set to None
Debt / FCF = 9.56 (Debt 4.26b / FCF TTM 445.2m)
Total Stockholder Equity = 2.81b (last 4 quarters mean)
RoA = -11.63% (Net Income -1.09b, Total Assets 9.41b )
RoE = -38.96% (Net Income TTM -1.09b / Total Stockholder Equity 2.81b)
RoCE = -10.41% (Ebit -619.2m / (Equity 2.81b + L.T.Debt 3.14b))
RoIC = -19.51% (NOPAT -619.2m / Invested Capital 3.17b)
WACC = 3.71% (E(3.22b)/V(7.48b) * Re(8.06%)) + (D(4.26b)/V(7.48b) * Rd(1.72%) * (1-Tc(0.76)))
Shares Correlation 5-Years: -50.0 | Cagr: -0.14%
Discount Rate = 8.06% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 81.39% ; FCFE base≈297.7m ; Y1≈367.3m ; Y5≈626.7m
Fair Price DCF = 44.22 (DCF Value 10.64b / Shares Outstanding 240.6m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: -84.78 | Revenue CAGR: 0.0%
Rev Growth-of-Growth: -84.40
EPS Correlation: -36.26 | EPS CAGR: -25.53%
EPS Growth-of-Growth: 258.7